The HYPERION study examined whether adding sotatercept to other therapies for recently diagnosed patients with pulmonary arterial...

Patients with pulmonary arterial hypertension (PAH) often also have cardiovascular issues such as diabetes or heart disease. A new...

"Imagine being told that a new treatment exists — one that could save your life or significantly improve it — but that you’ll have to...

Angel Ouellet One day when I was six years old, I saw a favourite teacher at the end of the corridor at school and ran to give them a...

Rose Jardim When I was 50 years old, I cut myself while shaving my legs. And then the cut just didn’t heal. It developed into a deep...

Tarya Morel Looking back, I’ve had difficulties with shortness of breath for as long as I can remember, but it never really occurred to...

Cardiac index (CI) assesses the output of someone's heart based on their size. It measures heart function relative to the person's size...

The holiday season is the most critical fundraising period for charities, with many relying on year-end donations to sustain their work....

In an innovative new collaboration between Trillium Gift of Life Network (TGLN) and the provincial and federal governments, millions of...

INESSS recognizes sotatercept's therapeutic value but recommends against public funding Vancouver BC (5 December 2024) -- The Pulmonary...

As of December 1, the Ontario government has improved reimbursement amounts for people in Northern Ontario who need to travel for...

The ZENITH study examined whether adding sotatercept to people's ongoing therapies reduced the risk of death, lung transplantation, or...

Date: November 7, 2024 Location: Vancouver, BC   The Pulmonary Hypertension Association of Canada (PHA Canada) is thrilled to announce...

A webinar hosted by the Pulmonary Hypertension Knowledge Sharing Platform this week talked about a couple of studies on mental health in...

💜 RDSP Awareness Month is almost over , but it’s not too late to learn about the benefits of a Registered Disability Savings Plan (RDSP)...

Great news for the Pulmonary Hypertension (PH) community! Through the Canadian Drug Agency's (CDA) funding initiative for rare diseases,...

As most PH clinics are in large cities, PH patients living in rural or remote areas and who must travel long distances to their clinic...

PHA Canada is proud to announce our latest submission to the Patented Medicines Pricing Review Board (PMPRB)  this September. As the...

Merck has announced that WINREVAIR® (sotatercept) is now authorized for use in Canada in combination with standard pulmonary arterial...

Blog 4/6 - Getting there Guillaume and I love road-tripping! Ever since we met in 2001, we have frequently hit the road in search of...